Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.37 |
| ▸ | BAX | Q07812 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2064518 | 0.84 | CA4 (0.46) | CA4CA9CA6CA7CA14 | |
| SCHEMBL10652895 | 0.81 | TRPA1 (0.47) | TSHRTDP1MAPTCYP2C19ALDH1A1 | |
| Dinitrophenylene SCHEMBL27976876 | 0.78 | TSHR (0.55) | TSHRALOX15MAPTALDH1A1 | |
| SCHEMBL15477270 | 0.78 | CA4 (0.52) | CA4CA9CA6CA7CA14 | |
| SCHEMBL2001538 | 0.78 | CA4 (0.41) | CA4CA9CA6CA7CA14 | |
| SCHEMBL28278624 | 0.78 | CA4 (0.41) | CA4CA9CA6CA7CA14 | |
| SCHEMBL712975 | 0.78 | LTA4H (0.45) | CA4CA9CA6CA7CA14 | |
| SCHEMBL22719969 | 0.77 | MEN1 (0.48) | CA4CA9CA14LTA4HALOX15 | |
| SCHEMBL27707183 | 0.77 | CA9 (0.39) | CA4CA9CA6CA7CA14 | |
| SCHEMBL10702292 | 0.75 | TSHR (0.50) | CA6CA14TSHRALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1000 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4640716-A2 | METHODS FOR DETECTING RENAL DISEASE | IDEXX Laboratories, Inc. (US) | 2025-10-29 | — | — | EP | claimed |
| US-11739054-B2 | Methods and compositions for substance use disorder vaccine formulations and uses thereof | MOLECULAR EXPRESS, INC. (US) | 2023-08-29 | — | — | US | claimed |
| US-11628216-B2 | 6-acetylmorphine analogs, and methods for their synthesis and use | ALERE SAN DIEGO, INC. (US) | 2023-04-18 | — | — | US | claimed |
| US-20220080042-A1 | 6-ACETYLMORPHINE ANALOGS, AND METHODS FOR THEIR SYNTHESIS AND USE | ALERE SAN DIEGO, INC. | 2022-03-17 | — | — | US | claimed |
| EP-3458439-B1 | 2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE ANALOGS AND METHODS FOR THEIR SYNTHESIS AND USE | ALERE SAN DIEGO INC (US) | 2021-12-08 | — | — | EP | claimed |
| US-11192857-B2 | 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use | ALERE SAN DIEGO, INC. (US) | 2021-12-07 | — | — | US | claimed |
| US-20210239704-A1 | ANALOGS AND CONJUGATES OF BETA-AMINOISOBUTYRIC ACID (BAIB) | IDEXX LABORATORIES, INC. | 2021-08-05 | — | — | US | claimed |
| EP-3808733-A1 | METHODS FOR DETECTING SYMMETRICAL DEMETHYLARGININE | IDEXX Laboratories, Inc. (US) | 2021-04-21 | — | — | EP | claimed |
| US-20210107862-A1 | METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULATIONS AND USES THEREOF | MOLECULAR EXPRESS, INC. (US) | 2021-04-15 | — | — | US | claimed |
| US-20200115324-A1 | METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULATIONS AND USES THEREOF | MOLECULAR EXPRESS, INC. (US) | 2020-04-16 | — | — | US | claimed |
| WO-2010017089-A1 | METHODS FOR DETECTING SYMMETRICAL DEMETHYLARGININE | IDEXX LABORATORIES, INC. (US) | 2010-02-11 | — | — | WO | claimed |
| US-20090208451-A1 | HALOGEN PHOSPHONATE MONOESTERS | INTEGRIGEN, INC. (US) | 2009-08-20 | — | — | US | claimed |
| US-20080293920-A1 | Arginine Analogs, and Methods for Their Synthesis and Use | ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.) | 2008-11-27 | — | — | US | claimed |
| WO-2006078813-A2 | ARGININE ANALOGS, AND METHODS FOR THEIR SYNTHESIS AND USE | BIOSITE INCORPORATED (US) | 2006-07-27 | — | — | WO | claimed |
| WO-2005037228-A2 | HALOGEN PHOSPHONATE MONOESTERS | INTEGRIGEN, INC. (US) | 2005-04-28 | — | — | WO | claimed |
| US-6605265-B1 | Introducing hydrogen peroxide, ammonia and ketone or aldehyde into circulating reaction medium in azine reaction zone, withdrawing azine formed, heating medium, recycling to reaction zone, introducing reagent to maintain equilibrium | ATOCHEM (FR) | 2003-08-12 | — | — | US | claimed |
| EP-0796085-B1 | SOLUBILISATION AIDS FOR HYDROPHILIC MACROMOLECULES | PROVALIS UK LTD (GB) | 2000-05-17 | — | — | EP | claimed |
| US-5968549-A | Solubilisation aids | CORTECS (UK) LIMITED (GB) | 1999-10-19 | — | — | US | claimed |
| EP-0796085-A1 | SOLUBILISATION AIDS FOR HYDROPHILIC MACROMOLECULES | CORTECS LIMITED (GB) | 1997-09-24 | — | — | EP | claimed |
| WO-1996017593-A1 | SOLUBILISATION AIDS FOR HYDROPHILIC MACROMOLECULES | CORTECS LIMITED (GB) | 1996-06-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220080042-A1 | 6-ACETYLMORPHINE ANALOGS, AND METHODS FOR THEIR SYNTHESIS AND USE | DNPEP, CRHBP, AANAT | CA4 3445/4885CA9 3960/4885CA6 1147/4885 |
| US-20200115324-A1 | METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULATIONS AND USES THEREOF | TLR3, GAP43, MAG | CA4 2794/4885CA9 3931/4885CA6 2622/4885 |
| US-11628216-B2 | 6-acetylmorphine analogs, and methods for their synthesis and use | DNPEP, CRHBP, AANAT | CA4 3445/4885CA9 3960/4885CA6 1147/4885 |
| US-20090208451-A1 | HALOGEN PHOSPHONATE MONOESTERS | FCGRT, PTMS, DNPEP | CA4 113/4885CA9 288/4885CA6 335/4885 |
| US-20080293920-A1 | Arginine Analogs, and Methods for Their Synthesis and Use | PRMT1, PRMT5, ARGLU1 | CA4 3555/4885CA9 3952/4885CA6 3697/4885 |
| US-20210107862-A1 | METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULATIONS AND USES THEREOF | TLR3, GAP43, MAG | CA4 2794/4885CA9 3931/4885CA6 2622/4885 |
| US-11739054-B2 | Methods and compositions for substance use disorder vaccine formulations and uses thereof | TLR3, GAP43, MAG | CA4 2794/4885CA9 3931/4885CA6 2622/4885 |
| US-20210239704-A1 | ANALOGS AND CONJUGATES OF BETA-AMINOISOBUTYRIC ACID (BAIB) | GABRB1, GABRB2, GABRB3 | CA4 1360/4885CA9 1079/4885CA6 1424/4885 |
| US-11192857-B2 | 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine analogs and methods for their synthesis and use | DPYSL2, DNPEP, DPYSL3 | CA4 4230/4885CA9 4564/4885CA6 4291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.